Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
World Neurosurg. 2014 Mar-Apr;81(3-4):520-8. doi: 10.1016/j.wneu.2014.01.004. Epub 2014 Jan 16.
To evaluate treatment options for brainstem cavernous malformations (BSCMs) using the results from a center with long-standing experience in microsurgical resection and Gamma Knife radiosurgery (GKRS) treatment of BSCMs.
Study participants were 67 symptomatic patients with BSCMs who were treated either microsurgically (n = 29) or radiosurgically (n = 38). Patients were followed for a minimum of 2 years (median, 7.7 years). A recent follow-up was performed.
Patients receiving surgical treatment had mainly large, superficially seated lesions and experienced preoperative hemorrhages more often and presented with higher preoperative modified Rankin Scale scores. Patients receiving GKRS harbored smaller, deep-seated lesions, reflecting a selection bias. In both treatment groups, patients presented with significantly better modified Rankin Scale scores at follow-up than before intervention. Overall annual preoperative hemorrhage rates were 3.2% in microsurgery patients and 2.3% in radiosurgery patients. In the preoperative observation period, the rehemorrhage rate was 25.1% for microsurgery patients and 7.2% for radiosurgery patients. Hemorrhage rate after GKRS decreased significantly to 0.6% after 2 years. The postoperative hemorrhage rate was 8.8% but only for microsurgery patients with residual lesions. Advancements in microsurgical techniques improved surgical outcomes, resulting in a high total excision rate in the modern era.
In the treatment of BSCM, patient selection and timing of surgery are crucial. If applied in a multidisciplinary neurosurgical center, microsurgery and radiosurgery are complementary treatment options that both result in reduced bleeding rates and improvement of clinical outcome.
利用在脑干海绵状畸形(BSCM)的显微切除术和伽玛刀放射外科(GKRS)治疗方面具有长期经验的中心的结果,评估脑干海绵状畸形的治疗选择。
研究参与者为 67 例有症状的 BSCM 患者,他们分别接受显微手术(n=29)或放射外科治疗(n=38)。患者的随访时间至少为 2 年(中位数为 7.7 年)。最近进行了随访。
接受手术治疗的患者主要有大的、表浅性病变,术前出血更频繁,术前改良 Rankin 量表评分更高。接受 GKRS 治疗的患者病变较小、较深,这反映了一种选择偏倚。在这两种治疗组中,患者在随访时的改良 Rankin 量表评分明显优于干预前。在显微外科组和放射外科组中,患者的总体术前年度出血率分别为 3.2%和 2.3%。在术前观察期,显微外科组的再出血率为 25.1%,放射外科组为 7.2%。GKRS 后出血率在 2 年内显著下降至 0.6%。术后出血率为 8.8%,但仅适用于有残留病变的显微外科患者。显微外科技术的进步改善了手术结果,导致现代时代的总切除率很高。
在 BSCM 的治疗中,患者选择和手术时机至关重要。如果在多学科神经外科中心应用,显微手术和放射外科是互补的治疗选择,均可降低出血率并改善临床结果。